SIRPA and neoplasm: Similarly, miR-17, miR-20a, and miR-106a, when activated by lipopolysaccharide (LPS), have been reported to cause reduced signal regulatory protein α (SIRPα) expression, and promote pro-inflammatory cytokine secretion, (93) thus initiating an anti-tumor immune response.